Emsella for Reducing tSUI After HOLEP
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Northwestern University
- Study ID
- NCT07580404
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Benign Prostatic Hyperplasia
- Enlarged Prostate (BPH)
- Enlarged Prostate With Lower Urinary Tract Symptoms
Eligibility Criteria
- Sex
- MALE
- Age
- 50 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- Emsella chair — DEVICEEmsella is a non-invasive treatment used to activate and strengthen the pelvic floor. One Emsella treatment is reported to be the equivalent of performing 11,000 Kegel exercises.
Study Details
This study aims to investigate the effectiveness of the Emsella chair treatments at different timepoints. Before and after the holmium laser enucleation of the prostate (HoLEP).
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- May 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- No Intervention: Standard Care (Kegel Exercises)Patients are reminded to perform pelvic floor exercises known as Kegel exercises for 3 weeks leading up to their scheduled HoLEP procedure, and continue Kegel exercises for 3 weeks following the HoLEP procedure.
- Active Comparator: Pre-HoLEP EmsellaParticipants will complete 2 30-minute Emsella treatment sessions for 3 weeks (for a total of 6 30-minute Emsella chair treatment sessions) leading up to their scheduled HoLEP procedure. They will undergo the HoLEP 1 week after the final Emsella treatment session.
- Active Comparator: Post-HoLEP EmsellaParticipants will complete 2 30-minute Emsella treatment sessions for 3 weeks (for a total of 6 30-minute Emsella chair treatment sessions) following their scheduled HoLEP procedure. They will begin their first Emsella treatment session 1 week after HoLEP.
Primary Outcome Measure
Difference in Michigan Incontinence Score (M-ISI) [ Time Frame: Pre-HoLEP, 4 weeks, 6 weeks, 8 weeks, 12 weeks post-HoLEP ]
Central Contacts
- Alyssa McDonald, MPH312-695-8146
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northwestern University | Chicago | Illinois | 60611 | Alyssa McDonald, MPH |
Find similar trials in Chicago, IL
By research site
Related Studies
- Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported OutcomesRecruiting · Northwestern University · Glenview, Illinois
- A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia SymptomsRecruiting · Rivermark Medical · Bakersfield, California
- Ejaculatory-Sparing HoLEP vs Standard HoLEPRecruiting · Northwestern University · Chicago, Illinois
- Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled TrialRecruiting · Northwestern University · Chicago, Illinois